跳至主要内容
临床试验/TCTR20190225002
TCTR20190225002已完成4 期

Role of oral iron supplement in non-variceal upper gastrointestinal bleeding

Hatyai Hospital Foundation0 个研究点目标入组 168 人开始时间: 2019年2月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1. non variceal upper gastrointestinal bleeding who admited in hospital
  • 2. age between 18-75 years
  • 3. who was diagnosed with anemia secondary to UGIB on the day of inclusion (Anemia was defined according to the definitions of the World Health Organization (WHO): hemoglobin level lower than 12 g/dL for women and 13 g/dL for men)

排除标准

  • (1) pregnant or nursing mothers
  • (2) pathologies that could influence anemia progression (including chronic renal failure, decompensated cirrhosis, cancer, presence of systemic inflammatory response syndrome [SIRS] or sepsis)
  • (3) history of overt UGIB within 3 months prior to inclusion
  • (4) previous iron supplementation intake within 3 months
  • (5) history of chronic anemia or treatment of erythropoietin
  • (6) contraindication of iron use (e.g., hemochromatosis, thalassemia major, and history of allergy to oral iron medicine)

研究者

发起方
Hatyai Hospital Foundation

相似试验